OIG Issues Medicare Advantage Industry Segment-Specific Compliance Program Guidance, Creating Implications For Downstream Entities

The U.S. Department of Health and Human Services' Office of Inspector General (OIG) has released updated Medicare Advantage Industry Segment-Specific Compliance Program Guidance (ICPG), providing a comprehensive fraud and abuse risk framework tailored to the Medicare Advantage program. While directed primarily at Medicare Advantage organizations, the ICPG makes clear that compliance risk in Medicare Advantage extends beyond the plan entity. First-tier, downstream and related entities (FDRs)—including delegated vendors, independent physician associations, management services organizations, risk-bearing physician groups and marketing partners—are deeply embedded in the risk areas OIG highlights. For organizations participating in the Medicare Advantage ecosystem, the ICPG functions as both a compliance benchmark and an enforcement roadmap.

What Is the ICPG?

The ICPG updates OIG's longstanding compliance program guidance to reflect:

• The scale and growth of Medicare Advantage enrollment
• Persistent risk adjustment vulnerabilities
• Prior authorization and utilization management scrutiny
• Marketing and broker compensation concerns
• Data integrity and reporting risk

The document outlines OIG's view of key fraud and abuse risk areas and provides expectations for compliance program design, oversight, monitoring and auditing. Historically, OIG compliance guidance has foreshadowed enforcement priorities.

Core Risk Areas Identified by OIG

Risk Adjustment and Diagnosis Coding

OIG continues to emphasize unsupported diagnosis submissions, in-home assessment abuses, chart review manipulation and vendor-driven coding inflation. Given the centrality of risk scores to Medicare Advantage revenue, this remains the most significant enforcement exposure area. Downstream implications include coding vendors, analytics companies, risk-bearing provider groups and MSOs managing documentation workflows.

Utilization Management and Prior Authorization

OIG highlights concerns related to inappropriate denials, failure to follow Medicare coverage rules, incentive structures tied to denial rates and delegated utilization management arrangements. Where utilization management functions are delegated, OIG expects active oversight by the Medicare Advantage organization and operational compliance by the delegate.

Marketing and Broker Compensation

OIG signals risk in lead generation arrangements, third-party marketing organizations, compensation structures that may drive inappropriate enrollment and misleading beneficiary communications. Downstream marketing partners are a clear focus area.

FDR Oversight and Delegation

The ICPG reinforces that Medicare Advantage organizations must conduct meaningful oversight of FDRs, audit delegated entities and ensure compliance training and reporting mechanisms. For downstream entities, this could mean increased audit frequency, heightened documentation demands and greater contractual scrutiny.

Data Integrity and Reporting

OIG emphasizes encounter data accuracy, timely reporting, systems integrity and controls around data submissions. Technology vendors, analytics providers and MSOs managing submission workflows should expect heightened diligence in this area.

What This Means for Downstream Entities

Although Medicare Advantage plans bear ultimate regulatory responsibility, downstream entities may face contract termination, repayment exposure, indemnification claims, exclusion risk, False Claims Act scrutiny and whistleblower actions. The ICPG signals that OIG will examine not only the plan entity, but also operational actors influencing risk scores, utilizations decisions and marketing conduct.

Practical Compliance Steps

Organizations participating in Medicare Advantage should consider:

• Conducting a compliance program gap assessment benchmarked to ICPG expectations
• Reviewing risk adjustment controls and vendor oversight mechanisms
• Reassessing FDR monitoring and delegation frameworks
• Examining compensation models for fraud and abuse risk
• Educating board members and executive leadership in Medicare Advantage-specific enforcement priorities

If your organization participates in Medicare Advantage—whether as an independent physician association, management services organization, vendor or delegated partner—now is an appropriate time to evaluate alignment with OIG's updated guidance.

For More information

If you have any questions about this Alert, please contact Neville M. Bilimoria, Erin M. Duffy, Ryan Wesley Brown, Kelechi Anyatonwu, any of the attorneys in our Health Law Practice Group or the attorney in the firm with whom you are regularly in contact.

Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, nor should be construed, as legal advice. For more information, please see the firm's full disclaimer.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.